SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsLowNeutral
Announced Mon, 6 Apr · 15:06 IST

Shilpa Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Promoter Below 50pctOwnership Changes View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹387.70
prior close
₹392.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.4-0.2+4.7+8.0+8.8+7.3+6.1+5.5+13.7+36.9+53.7
Up moveDown movePending
AI summary

Shilpa Medicare Limited has submitted the yearly disclosure under SEBI Regulation 31(4) for the financial year ended 31 March 2026, filed by promoter Omprakash Innani on behalf of the promoter group and persons acting in concert. The promoter group collectively holds 7,84,96,648 shares, representing 40.13% of the company's total share capital. Annexure 1 reveals that around 68.5 lakh shares (~3.49% of total shares) held by six promoter group members are currently pledged or encumbered. The filing is a routine annual compliance requirement and confirms there have been no triggers requiring disclosures of any acquisition or disposal crossing the takeover thresholds during the year.

Likely market impact

The promoter group holding stands at 40.13%, well below the 50% majority mark, meaning promoters do not have absolute control and any further encumbrance or sale could be sensitive for shareholders. The pledged portion (~3.49%) is modest and not alarming, but investors should monitor any pledge invocations which could pressure the stock.